• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·002001.SZ
Share

Bitcoin USD Price Stocks

CN¥ 30.09Last Updated 12.06.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 13.72B

CN¥ 30.09
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang, China, specializes in the nationwide production and distribution of a broad spectrum of chemical products. Its principal operations are divided into four main categories: 1. Nutritional Products: The company offers a comprehensive range of supplements, including essential vitamins (E, A, C, D3, biotin), DL-Methionine, coenzyme Q10, and various carotenoids. These ingredients are critical for enhancing animal feed and fortifying food, beverages, and health-related products. 2. Flavors and Fragrances: This segment supplies a variety of aroma chemicals, such as derivatives from the linalool and citral series, cis-3-hexenol, methyl dihydrojasmonate, raspberry ketone, and ligustral, which are widely utilized in personal care items, cosmetic formulations, and food flavorings. 3. New Polymer Materials: Zhejiang NHU provides advanced polymer solutions like polyphenylene sulfide and polyphthalamide. These materials find essential applications across industries including electronics, automotive manufacturing, and environmental protection. 4. Active Pharmaceutical Ingredients (APIs): The company manufactures crucial pharmaceutical components, including moxifloxacin hydrochloride, vitamin A, and vitamin D3, which serve as foundational substances for the development and production of various drug preparations.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, reasonably priced

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 002001.SZ is 38 and suggests 28% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026